FibroBiologics (FBLG) Assets Average (2024 - 2026)
FibroBiologics (FBLG) posted quarterly Assets Average of $6.9 million for Q2 2026, down 45.26% year-over-year from $12.7 million in Q2 2025, and down 10.86% on a QoQ basis from $7.8 million in Q1 2026.
FibroBiologics (FBLG) Assets Average (2024 - 2026) Analysis & Trends
FibroBiologics has reported Assets Average for 3 years, with the latest figure at $6.9 million in Q2 2026.
- Assets Average for Q2 2026 came in at $6.9 million, down 45.26% year-over-year; the trailing twelve-month figure through Jun 2026 was $6.9 million (down 45.26% YoY), and the FY2025 annual result was $13.0 million, down 7.79% from the prior year.
- Assets Average fell to $6.9 million in Q2 2026, from $7.8 million in the prior quarter.
- Over five years, Assets Average peaked at $13.9 million in Q1 2025 and troughed at $6.9 million in Q2 2026.
- A 3-year average of $10.7 million and a median of $10.7 million in 2024 frame the typical range for Assets Average.
- The widest annual swing landed in 2025, when Assets Average rose 24.73%; it then slumped 45.26% in 2026.
- A 3-year view of Assets Average shows it stood at $13.5 million in 2024, then sank by 31.77% to $9.2 million in 2025, then decreased by 24.48% to $6.9 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $6.9 million in Q2 2026, $7.8 million in Q1 2026, and $9.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | FibroBiologics | 8.15 Mn | 8.15 Mn | - | 6.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.93 Mn |
| Mar 31, 2026 | 7.78 Mn |
| Dec 31, 2025 | 9.18 Mn |
| Sep 30, 2025 | 11.33 Mn |
| Jun 30, 2025 | 12.67 Mn |
| Mar 31, 2025 | 13.94 Mn |
| Dec 31, 2024 | 13.46 Mn |
| Sep 30, 2024 | 9.69 Mn |
| Jun 30, 2024 | 10.16 Mn |
| Mar 31, 2024 | 11.61 Mn |